IL-4 signaling, gene transcription regulation, and the control of effector T cells

Immunologic Research

Volumn 23, Issue 2-3, 2001, Pages 179-191

  Boothby, M ^a   Mora, A L ^a   Aronica, M A ^a   Youn, J ^a   Sheller, J R ^a   Goenka, S ^a   Stephenson, L ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Asthma; Gene Regulation; IL 4; Memory; Mouse Models; NF kappa; Th1; Th2

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR;

ARTICLE; EFFECTOR CELL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HELPER CELL; IMMUNE RESPONSE; LYMPHOCYTE DIFFERENTIATION; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; TRANSCRIPTION REGULATION;

ADOPTIVE TRANSFER; ANIMALS; ASTHMA; CHROMATIN; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B PROTEINS; IMMUNOLOGIC MEMORY; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICE, TRANSGENIC; NF-KAPPA B; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, INTERLEUKIN-4; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS; TH2 CELLS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0034989395     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:23:2-3:179     Document Type: Article

References (82)

1. Lymphocyte responses and cytokines
2. Functional diversity of helper T lymphocytes
3. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes
4. Immunological aspects of allergic asthma
5. Immunologic basis of antigen-induced airway hyper-responsiveness
6. Phenotype of cells expressing mRNA for TH2-type (interkeukin 4 and interleukin 5) and TH1 -type (interleukin 2 and interferon γ) cytokines in broncho-alveolar lavage and bronchial biopsies from atopic asthmatic and normal control sunbjects
7. Exposure to T helper 2 cytokines in vivo before encounter with antigen selects for T helper subsets via alterations in antigen-presenting cell function
8. CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes
9. + and CD8α subclasses of dendritic cells direct the development of distinct T helper cells in vivo
10. Generation of interleukin (IL-) 4-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells
11. + T cells to enhance priming for IFN-γ production and diminishes IL-4 inhibition of such priming
12. IGIF does not drive Th1 development but synergizes with IL-12 for Interferon-γ production and activates IRAK and NF-κB
13. Lack of IL-4-induced Th2 response and IgE class switching in mice with a disrupted Stat6 gene
14. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells
15. Stat6-independent GATA-3 auto-activation directs IL-4-independent Th2 development and commitment
16. Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc
17. The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines
18. A critical role for NF-[kappa]B in Gata3 expression and TH2 differentiation in allergic airway inflammation
19. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation
20. + lymphocytes with a Th2 cytokine profile
21. + T cell IL-4 production is revealed in IL-4 receptor-deficient mice
22. Star6 regulation of in vivo IL-4 responses
23. Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells
24. IL-4 and IL- 13 production in differentiated T helper type 2 cells is not IL-4 dependent
25. IL- 12-deficient mice are defective in IFN-γ production and type I cytokine responses
26. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells
27. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo
28. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1
29. Paired Stat6 C-terminal transcription activation domains required both for inhibition of an interferon-responsive promoter and for trans-activation
30. Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB
31. IL-12 induces IFN regulating factor-1 (IRF-1) gene expression in human NK and T cells
32. Targeted disruption of the MyD88 gene results in loss of IL-1α and IL-18-mediated function
33. Re1/NF-κB/IκB family: Intimate tales of association and dissociation
34. NF-κB and Re1 proteins: Evolutionarily conserved mediators of immune responses
35. Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kappa B
36. + T cells in their dependence on NF-κB/Re1 signaling
37. Preferential role for NF-κB/Rel signaling in the type 1 but not type 2 T cell-dependent immune response in vivo
38. Interaction of NF-κB and NFAT with the interferon-γ promoter
39. A novel transcription factor, T-bet, directs Th1 lineage commitment
40. Regulation of the interleukin (IL)-12R beta 2 sub-unit expression in developing T helper 1 (Th1) and Th2cells
41. The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge
42. The IL-4 receptor: Signaling mechanisms and biologic functions
43. Jaks, STATs, cytokine signal transduction, and immuno-regulation: Are we there yet?
44. Interaction of Stat6 and NF-kappaB: Direct association and synergistic activation of interleukin-4-induced transcription
45. IRS-1: Essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells
46. PI 3-kinase and pp70 S6K signaling during insulin, IGF- 1, and IL-4 stimulation
47. An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth
48. Rapamycin inhibits interleukin 4-inducible phosphorylation of HMG-I(Y)
49. HMG-1(Y) phosphorylation status as a nuclear target regulated through the I4R motif of the IL-4 receptor
50. The non-histone chromosomal protein HMG-I(Y) contributes to repression of the immunoglobulin heavy chain germline epsilon promoter
51. The high mobility group protein HMG I(Y) is required for NF-kappa B-dependent virus induction of the human IFN-beta gene
52. IL-4-dependent induction of Bcl-2 and Bcl-X in T lymphocytes through a Stat6- and PI 3-kinase-independent pathway
53. The interleukin-4 receptor activates STAT5 by a mechanism that relies upon common gamma-chain
54. T cell receptor-induced calcineurin activation regulates T helper type 2 cell development by modifying the interleukin 4 receptor signaling complex
55. Mechanisms of NF-κB/Rel participation in the lymphokine-dependent proliferation oft lymphoid cells
56. Star5 activation is uniquely associated with cytokine signaling in peripheral T cells
57. In vivo function of an IL-2Rβ/IL-4Rα cytokine receptor chimera potentiates allergic airway disease
58. Redirection oft cell effector function in vivo and enhanced collagen-induced arthritis mediated by an IL-2Rβ/IL-4Rα chimeric cytokine receptor transgene
59. Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor
60. Cloning of mouse and human Stat6, proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis
61. Activation of STAT6 is not dependent on phosphotyrosine-mediated docking to the interleukin-4 receptor and can be blocked by dominant-negative mutants of both receptor subunits
62. Asthma: An epidemic in the absence of infection?
63. Developing patterns of T cell memory to environmental allergens in the first two years of life
64. Environmental risk factors in childhood asthma
65. T-lymphocyte dysregulation in asthma
66. IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1 cells
67. Interleukin- 13 is a more potent inhibitor of the express ion of inducible nitric oxide synthase in smooth muscle cells than in macrophages: A comparison with interleukin-4 and interleukin-10
68. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells
69. Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the gluco-corticoid budesonide
70. Inducible expression of a Th2-type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells
71. Consequences of long-term inflammation: Airway remodeling
72. Th Type 1-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-γ-dependent mechanism
73. T cell memory
74. Generation and in vivo persistence of polarized Th1 and Th2 memory cells
75. + T lymphocytes in vivo
76. Peripheral selection of T cell repertoires: The role of continuous thymus output
77. The role of the thymus and recent thymic migrants in the maintenance of the adult peripheral lymphocyte pool
78. T cells compete for access to antigen-bearing antigen-presenting cells
79. Memory T cell development in the absence of specific antigen priming
80. Functional differentiation of T cells in the intestine of T cell receptor transgenic mice
81. + T cells instructs Th2 development and susceptibility to leishmania major in BALB/c mice
82. - T cells in non-MHC gene-controlled predisposition toward skewing into T helper type-2 immunity in BALB/c mice